← Back to Search

Device

Stable airway management (SAM) device for Anesthesia

N/A
Waitlist Available
Led By Visnal Yajnik, MD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new device called the Stable Airway Management (SAM) device. It is designed to keep a patient's head and airway steady during procedures that require anesthesia. The study will evaluate the effectiveness of this new device.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Subjects Converted From MAC to General Anesthesia
Total Apneic Events /Total Number Requiring Airway Manipulation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
An investigational device will be used to hold patient's head and airway in a stable position.
Group II: Standard of careActive Control1 Intervention
Pillows and towels will be used to hold patient's head and airway in a stable position.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stable airway management (SAM) device
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
716 Previous Clinical Trials
22,888,458 Total Patients Enrolled
Visnal Yajnik, MDPrincipal InvestigatorVirginia Commonwealth University
~12 spots leftby Nov 2025